SCHEMBL3360046

SCHEMBL3360046

CC(C)CC(NC(=O)c1cc(=O)[nH]c(=O)[nH]1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRN P28799 3/20 0.51
SORT1 Q99523 3/20 0.51
ALDH1A1 P00352 4/20 0.48
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
GPR84 Q9NQS5 3/20 0.47
LMNA P02545 2/20 0.46
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
CYP1A2 P05177 1/20 0.45
FOLH1 Q04609 1/20 0.45
CA2 P00918 2/20 0.44
CA1 P00915 1/20 0.44
AKR1B1 P15121 2/20 0.43
MEN1 O00255 1/20 0.43
BCL2L1 Q07817 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3433459 0.84 GPR84 (0.41) GRNSORT1ALDH1A1KMT2AKDM4E
SCHEMBL21185729 0.83 ALDH1A1 (0.49) ALDH1A1KMT2AGPR84LMNACYP1A2
SCHEMBL11979054 0.81 LMNA (0.53) ALDH1A1KMT2AKDM4EGPR84LMNA
SCHEMBL28577021 0.81 KDM4E (0.47) ALDH1A1KDM4EGPR84LMNACYP1A2
SCHEMBL21185586 0.81 KDM4E (0.47) ALDH1A1KDM4EGPR84LMNACYP1A2
Hydrochloric Acid SCHEMBL28578292 0.80 KDM4E (0.46) ALDH1A1KDM4EGPR84LMNACYP1A2
SCHEMBL3433136 0.77 GPR84 (0.49) ALDH1A1KMT2AGPR84LMNACYP1A2
SCHEMBL25197064 0.75 TAS1R3 (0.78) LMNATAS1R3TAS1R1
SCHEMBL25517392 0.75 TAS1R3 (0.78) LMNATAS1R3TAS1R1
SCHEMBL20853657 0.75 TAS1R3 (0.78) LMNATAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8236952-B2 Preparations containing amino acids and orotic acid Northern Innovations Holding Corp. (CA) 2012-08-07 US disclosed
US-8236952-B2 Preparations containing amino acids and orotic acid Northern Innovations Holding Corp. (CA) 2012-08-07 US disclosed
US-8236952-B2 Preparations containing amino acids and orotic acid Northern Innovations Holding Corp. (CA) 2012-08-07 US disclosed
EP-2231622-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID Northern Innovations and Formulations Corp. (CA) 2010-09-29 EP disclosed
WO-2009076743-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-25 WO disclosed
WO-2009076743-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-25 WO disclosed
US-20090156812-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-18 US disclosed
US-20090156812-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-18 US disclosed
US-20090156812-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156812-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID DDC, ODC1, OTC GRN 3002/4885SORT1 1948/4885ALDH1A1 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.